About cetuxa 20 mg
Take advantage of the hot-selling Cetuxa 20 mg - a top-tier monoclonal antibody for targeted oncology therapy. Pick yours to experience a perfect formulation that conforms to USP/EP standards, ensuring unmatched quality. Each single-use, lustrous glass vial contains Cetuximab 20 mg lyophilized powder, designed for intravenous infusion only, with a precise reconstitution concentration of 2 mg/mL. Cetuxa is indicated for the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck. Always prescribed by a healthcare professional, this highly purified IgG1 antibody targets EGFR, delivering confident clinical results.
Exceptional Features & Clinical Advantages
Cetuxa 20 mg stands out with its highly purified IgG1 monoclonal antibody, offering selective EGFR targeting. Its perfect white-to-off-white lyophilized powder ensures ease of reconstitution with sterile water for a 2 mg/mL preparation. This product provides robust activity against metastatic colorectal cancer and squamous cell carcinoma of the head and neck. Its competitive advantages include conformance to international USP/EP standards and stringent patient safety, available only under prescription by medical professionals.
Reliable Supply, Domestic Reach, and Competitive Pricing
We estimate prompt, scalable supply ability to meet clinical oncology demands throughout major domestic markets. Cetuxa 20 mg is delivered efficiently from our FOB port locations, ensuring optimal condition and traceability. The outlay for procurement is balanced with premium quality and patient trust, making it a dependable choice for importers, distributors, and healthcare providers nationwide.
FAQ's of cetuxa 20 mg:
Q: How is Cetuxa 20 mg prepared for administration?
A: Cetuxa 20 mg must be reconstituted with Sterile Water for Injection to achieve a concentration of 2 mg/mL, then administered as an intravenous infusion under medical supervision.
Q: What are the primary indications for Cetuxa 20 mg?
A: Cetuxa 20 mg is indicated for the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck as part of anti-EGFR therapy.
Q: When should Cetuxa 20 mg be used by patients?
A: Cetuxa 20 mg should be used only when prescribed by qualified healthcare professionals, in line with its specified therapeutic indications.
Q: What are the storage instructions for Cetuxa 20 mg?
A: Store Cetuxa 20 mg at 2C to 8C, protect from light, and do not freeze to maintain product potency and safety.
Q: Where can Cetuxa 20 mg be sourced?
A: Cetuxa 20 mg is available through licensed distributors, exporters, suppliers, and trading partners as indicated by the manufacturer.
Q: What are the key benefits of choosing Cetuxa 20 mg?
A: The key benefits include a highly purified formulation, compliance with international standards, robust clinical efficacy in cancer therapy, and patient safety through prescription-only access.